LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.79
(0.0%)
CNY 7.79
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -380 Million CNY | 0.54% |
| 2022 | -382.08 Million CNY | -6.3% |
| 2021 | -359.43 Million CNY | 6.88% |
| 2020 | -385.97 Million CNY | 8.13% |
| 2019 | -420.13 Million CNY | 6.28% |
| 2018 | -448.29 Million CNY | -1243.96% |
| 2017 | 39.18 Million CNY | 112.62% |
| 2016 | -310.45 Million CNY | 37.13% |
| 2015 | -493.81 Million CNY | -97.81% |
| 2014 | -249.64 Million CNY | -559.68% |
| 2013 | -37.84 Million CNY | 66.21% |
| 2012 | -112 Million CNY | 54.74% |
| 2011 | -247.47 Million CNY | -1150.24% |
| 2010 | -19.79 Million CNY | -167.66% |
| 2009 | 29.25 Million CNY | -43.45% |
| 2008 | 51.73 Million CNY | 21.99% |
| 2007 | 42.4 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -339.21 Million CNY | 10.73% |
| 2024 Q3 | -341.62 Million CNY | -5.14% |
| 2024 Q2 | -323.63 Million CNY | 4.59% |
| 2023 Q3 | -274.68 Million CNY | 10.23% |
| 2023 FY | -380 Million CNY | 0.54% |
| 2023 Q2 | -305.98 Million CNY | 12.12% |
| 2023 Q4 | -380 Million CNY | -38.34% |
| 2023 Q1 | -348.18 Million CNY | 8.87% |
| 2022 Q2 | -369.44 Million CNY | 0.24% |
| 2022 Q4 | -382.08 Million CNY | -44.6% |
| 2022 FY | -382.08 Million CNY | -6.3% |
| 2022 Q1 | -370.33 Million CNY | -3.03% |
| 2022 Q3 | -264.23 Million CNY | 28.48% |
| 2021 FY | -359.43 Million CNY | 6.88% |
| 2021 Q1 | -357.65 Million CNY | 7.34% |
| 2021 Q2 | -376.45 Million CNY | -5.26% |
| 2021 Q3 | -254.67 Million CNY | 32.35% |
| 2021 Q4 | -359.43 Million CNY | -41.13% |
| 2020 Q2 | -373.31 Million CNY | 7.0% |
| 2020 Q1 | -401.39 Million CNY | 4.46% |
| 2020 Q4 | -385.97 Million CNY | -13.4% |
| 2020 Q3 | -340.37 Million CNY | 8.82% |
| 2020 FY | -385.97 Million CNY | 8.13% |
| 2019 Q4 | -420.13 Million CNY | -6.8% |
| 2019 FY | -420.13 Million CNY | 6.28% |
| 2019 Q2 | -411.58 Million CNY | -1246.87% |
| 2019 Q1 | 35.88 Million CNY | 108.01% |
| 2019 Q3 | -393.36 Million CNY | 4.43% |
| 2018 Q3 | 236.58 Million CNY | 429.15% |
| 2018 Q1 | 42.04 Million CNY | 7.29% |
| 2018 FY | -448.29 Million CNY | -1243.96% |
| 2018 Q4 | -448.29 Million CNY | -289.49% |
| 2018 Q2 | -71.87 Million CNY | -270.96% |
| 2017 Q3 | -34.45 Million CNY | 72.38% |
| 2017 Q4 | 39.18 Million CNY | 213.72% |
| 2017 FY | 39.18 Million CNY | 112.62% |
| 2017 Q1 | -343.77 Million CNY | -10.73% |
| 2017 Q2 | -124.76 Million CNY | 63.71% |
| 2016 Q2 | -337.75 Million CNY | 18.05% |
| 2016 FY | -310.45 Million CNY | 37.13% |
| 2016 Q4 | -310.45 Million CNY | -0.7% |
| 2016 Q3 | -308.28 Million CNY | 8.73% |
| 2016 Q1 | -412.13 Million CNY | 17.4% |
| 2015 Q4 | -498.97 Million CNY | 30.23% |
| 2015 Q1 | -711.31 Million CNY | -184.93% |
| 2015 Q2 | -723.14 Million CNY | -1.66% |
| 2015 Q3 | -715.14 Million CNY | 1.11% |
| 2015 FY | -493.81 Million CNY | -97.81% |
| 2014 Q4 | -249.64 Million CNY | 8.44% |
| 2014 FY | -249.64 Million CNY | -559.68% |
| 2014 Q3 | -272.65 Million CNY | -8.35% |
| 2014 Q2 | -251.64 Million CNY | -28.28% |
| 2014 Q1 | -196.17 Million CNY | -418.39% |
| 2013 Q3 | -52.73 Million CNY | 34.54% |
| 2013 FY | -37.84 Million CNY | 66.21% |
| 2013 Q1 | -86.56 Million CNY | 22.71% |
| 2013 Q2 | -80.56 Million CNY | 6.94% |
| 2013 Q4 | -37.84 Million CNY | 28.24% |
| 2012 Q3 | -103.35 Million CNY | 23.04% |
| 2012 Q2 | -134.29 Million CNY | 27.52% |
| 2012 Q1 | -185.28 Million CNY | 25.13% |
| 2012 FY | -112 Million CNY | 54.74% |
| 2012 Q4 | -112 Million CNY | -8.37% |
| 2011 Q4 | -247.47 Million CNY | -770.5% |
| 2011 Q3 | 36.9 Million CNY | -21.42% |
| 2011 FY | -247.47 Million CNY | -1150.24% |
| 2011 Q2 | 46.96 Million CNY | 0.0% |
| 2010 FY | -19.79 Million CNY | -167.66% |
| 2010 Q4 | -19.79 Million CNY | 0.0% |
| 2009 FY | 29.25 Million CNY | -43.45% |
| 2008 FY | 51.73 Million CNY | 21.99% |
| 2007 FY | 42.4 Million CNY | 0.0% |